After receiving the FDA’s greenlight for Hunter syndrome drug Avlayah, Denali Therapeutics CEO Ryan Watts saw the culmination of 20 years of hard work unraveling the mysteries of the blood-brain barrier.
While prominent physicians can provide companies with valuable guidance during development, their perspective is limited when it comes to projecting how well or how readily a new product will be adopted. Here’s how to perform rigorous commercial diligence.
The Governmental Accounting Standards Board debuted a series of videos to help officials understand the information included in government financial reports.
While the specific impacts are still being determined, professional liability insurers that cover CPA firms increasingly are coming to a consensus that AI is a source of risk that must be controlled by strong governance.
Kentucky has become the latest state to pass legislation offering an alternative pathway to qualifying for a CPA license to broaden the talent pipeline.
Officials in some states are seeking to regulate prediction markets like casinos, requiring the companies to apply for state licenses and pay state taxes.